Introduction

Tom Blackett
Additional contact information
Tom Blackett: Interbrand

A chapter in Brand Medicine, 2001, pp 1-5 from Palgrave Macmillan

Abstract: Abstract It seems extraordinary that one of the world’s largest consumer good markets — pharmaceuticals — should for so long have flourished with little help from brands. In most other industries, manufacturers, suppliers of services and retailers use branding techniques to help secure competitive advantage. Indeed, increasingly these days, it is the brand which provides the sole means of differentiation, as Fortune magazine famously said: In the 21st century, branding ultimately will be the only unique differentiator between companies. Brand equity is now a key asset. What Fortune is asserting is that sooner or later, given the increasing ubiquity of capital, technology and skilled workforces, most companies in most industries will be competing on a level playing field. In these circumstances the reputation encapsulated in their brands will become the chief determinant of customer choice.

Keywords: Pharmaceutical Industry; Trade Mark; Brand Equity; Perfect Competition; Skilled Workforce (search for similar items in EconPapers)
Date: 2001
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-52251-0_1

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230522510

DOI: 10.1057/9780230522510_1

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().